A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations
- 29 January 2016
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 50 (4) , 311-325
Abstract
Objective: In settings where free phenytoin concentrations are not available, the Sheiner-Tozer equation—Corrected total phenytoin concentration = Observed total phenytoin concentration/[(0.2 × Albumin) + 0.1]; phenytoin in µg/mL, albumin in g/dL—and its derivative equations are commonly used to correct for altered phenytoin binding to albumin. The objective of this article was to provide a comprehensive and updated review on the predictive performance of these equations in various patient populations. Data Sources: A literature search of PubMed, EMBASE, and Google Scholar was conducted using combinations of the following terms: Sheiner-Tozer, Winter-Tozer, phenytoin, predictive equation, precision, bias, free fraction. Study Selection and Data Extraction: All English-language articles up to November 2015 (excluding abstracts) were evaluated. Data Synthesis: This review shows the Sheiner-Tozer equation to be biased and imprecise in various critical care, head trauma, and general neurology patient populations. Factors contributing to bias and imprecision include the following: albumin concentration, free phenytoin assay temperature, experimental conditions (eg, timing of concentration sampling, steady-state dosing conditions), renal function, age, concomitant medications, and patient type. Although derivative equations using varying albumin coefficients have improved accuracy (without much improvement in precision) in intensive care and elderly patients, these equations still require further validation. Conclusions: Further experiments are also needed to yield derivative equations with good predictive performance in all populations as well as to validate the equations’ impact on actual patient efficacy and toxicity outcomes. More complex, multivariate predictive equations may be required to capture all variables that can potentially affect phenytoin pharmacokinetics and clinical therapeutic outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Characterization of Unbound Phenytoin Concentrations in Neurointensive Care Unit Patients Using a Revised Winter-Tozer EquationAnnals of Pharmacotherapy, 2013
- Monitoring Free Drug Concentrations: ChallengesBioanalysis, 2011
- Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children*Pediatric Critical Care Medicine, 2006
- Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countriesInt. Journal of Clinical Pharmacology and Therapeutics, 2004
- Interpatient and Intrapatient Variability in Phenytoin Protein BindingTherapeutic Drug Monitoring, 2002
- Plasma Total Phenytoin: A Possibly Misleading Test in Developing CountriesTherapeutic Drug Monitoring, 1999
- Measurement and Analysis of Unbound Drug ConcentrationsClinical Pharmacokinetics, 1996
- Plasma Antiepileptic Drug Monitoring in a Neurological PracticeTherapeutic Drug Monitoring, 1994
- Clinical Response in Epilepsy in Relation to Total and Free Serum Levels of PhenytoinTherapeutic Drug Monitoring, 1991
- Diphenylhydantoin: Correlation between protein binding and albumin concentrationJournal of Molecular Medicine, 1975